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The combinatorial cross-regulation of hundreds of
sequence-specific transcription factors (TFs) defines
a regulatory network that underlies cellular identity
and function. Here we use genome-wide maps of
in vivo DNaseI footprints to assemble an extensive
core human regulatory network comprising connec-
tions among 475 sequence-specific TFs and to
analyze the dynamics of these connections across
41 diverse cell and tissue types. We find that human
TF networks are highly cell selective and are driven
by cohorts of factors that include regulators with
previously unrecognized roles in control of cellular
identity. Moreover, we identify many widely ex-
pressed factors that impact transcriptional regula-
tory networks in a cell-selective manner. Strikingly,
in spite of their inherent diversity, all cell-type regula-
tory networks independently converge on a common
architecture that closely resembles the topology
of living neuronal networks. Together, our results
provide an extensive description of the circuitry,
dynamics, and organizing principles of the human
TF regulatory network.
INTRODUCTION
Sequence-specific transcription factors (TFs) are the key effec-
tors of eukaryotic gene control. Human TFs regulate hundreds
to thousands of downstream genes (Johnson et al., 2007). Of
particular interest are interactions in which a given TF regulates
other TFs, or itself. Such mutual cross-regulation among groups
of TFs defines regulatory subnetworks that underlie major
features of cellular identity and complex functions such as
pluripotency (Boyer et al., 2005; Kim et al., 2008), development
(Davidson et al., 2002a), and differentiation (Yun and Wold,1274 Cell 150, 1274–1286, September 14, 2012 ª2012 Elsevier Inc.1996). On a broader level, cross-regulatory interactions among
the entire complement of TFs expressed in a given cell type
form a core transcriptional regulatory network, endowing the
cell with systems-level properties that facilitate the integration
of complex cellular signals, while conferring additional nimble-
ness and robustness (Alon, 2006). However, despite their cen-
tral biological roles, both the structure of core human regula-
tory networks and their component subnetworks are largely
undefined.
One of the main bottlenecks limiting generation of TF regula-
tory networks for complex biological systems has been that
information is traditionally collected from individual experiments
targeting one cell type and one TF at a time (Davidson et al.,
2002a; Yuh et al., 1994; Kim et al., 2008; Roy et al., 2010;
Gerstein et al., 2010). For example, the sea urchin endomeso-
derm regulatory network was constructed by individually per-
turbing the expression and activity of several dozen TFs and
analyzing the effect of these perturbations on the expression of
TF genes containing putative cis-regulatory binding elements
for these factors (Davidson et al., 2002b; Yuh et al., 1994). More
recently, genome-wide analysis combining chromatin immuno-
precipitation of individual TFs with high-throughput sequencing
(ChIP-seq) has been used to derive subnetworks of small
numbers of TFs, such as those involved in pluripotency (Kim
et al., 2008), or larger-scale networks combining several dozen
TFs (Roy et al., 2010; Gerstein et al., 2010). However, such
approaches are limited by three major factors: (1) the availability
of suitable affinity reagents; (2) the difficulty of interrogating the
activities of multiple TFs within the same cellular environment;
and, perhaps most critically, (3) the sizable number of TFs and
cellular states that need to be studied. De novo network
construction methods based on gene expression correlations
partly overcome the limitation of studying one TF at a time but
lack directness and typically require several hundred indepen-
dent gene expression perturbation studies to build a network
for one cell type (Basso et al., 2005; Carro et al., 2010). Similarly,
yeast one-hybrid assays offer a high-throughput approach for
identifying cis-regulatory element binding partners (Walhout,
2006; Reece-Hoyes et al., 2011). However, such assays lack
native cellular context, limiting their direct utility for building
cell-type-specific networks. Given these experimental limita-
tions, only a handful of well-described multicellular transcrip-
tional regulatory networks have been defined, and those that
do exist are often incomplete despite the numerous experiments
and extended time (typically years) needed to construct them
(Davidson et al., 2002a; Basso et al., 2005; Boyer et al., 2005;
Kim et al., 2008; Roy et al., 2010; Gerstein et al., 2010).
Given that the human genome encodes > 1,000 TFs (Vaquer-
izas et al., 2009) and that human cellular diversity spans
hundreds of different cell types and an even greater number
of cellular states, we sought to develop an accurate and scalable
approach to analyze transcriptional regulatory networks suitable
for the application to any cellular or organismal state. The dis-
covery of DNaseI footprinting over 30 years ago (Galas and
Schmitz, 1978) revolutionized the analysis of regulatory se-
quences in diverse organisms and directly enabled the discovery
of the first human sequence-specific TFs (Dynan and Tjian,
1983). In the context of living nuclear chromatin, DNaseI treat-
ment preferentially cleaves the genome within highly accessible
active regulatory DNA regions, creating DNaseI-hypersensitive
sites (DHSs) (Wu et al., 1979; Kuo et al., 1979; Wu, 1980; Stalder
et al., 1980). Within DHSs, DNaseI cleavage is not uniform but is
rather punctuated by sequence-specific regulatory factors that
occlude bound DNA, leaving ‘‘footprints’’ that demarcate TF
occupancy at nucleotide resolution (Hesselberth et al., 2009;
Pfeifer and Riggs, 1991). DNaseI footprinting is a well-estab-
lished method for identifying direct regulatory interactions and
provides a powerful generic approach for assaying the occu-
pancy of specific sequence elements with cis-regulatory func-
tions (Karin et al., 1984; Kadonaga et al., 1987).
DNaseI footprinting has been applied widely to study regula-
tory interactions between TFs and to identify cell- and lineage-
selective transcriptional regulators (Dynan and Tjian, 1983; Karin
et al., 1984; Tsai et al., 1989). In the context of the ENCODE
Project, we applied digital genomic footprinting (Hesselberth
et al., 2009) to delineate millions of human DNaseI footprints
genome-wide in 41 diverse cell types. Combining DNaseI foot-
prints with defined TF recognition sequences accurately and
quantitatively recapitulates ChIP-seq data for individual TFs,
while simultaneously interrogating the genomic occupancy of
potentially all expressed DNA-binding factors in a single
experiment (Neph et al., 2012a).
By performing systematic analysis of TF footprints in the
proximal regulatory regions of each TF gene, we develop a
foundational experimental paradigm for comprehensive, unbi-
ased mapping of the complex network of regulatory interac-
tions between human TFs. In such networks, TFs comprise
the network ‘‘nodes,’’ and the cross-regulation of one TF by
another the interactions or network ‘‘edges.’’ Furthermore, iter-
ating this paradigm across diverse cell types provides a powerful
system for analysis of TF network dynamics in a complex
organism. Here, we use genome-wide maps of in vivo DNaseI
footprints to assemble an extensive core human regulatory
network comprising connections among 475 sequence-specific
TFs and analyze the dynamics of these connections across 41
diverse cell and tissue types.CRESULTS
Comprehensive Mapping of TF Networks in Diverse
Human Cell Types
To generate TF regulatory networks in human cells, we analyzed
genomic DNaseI footprinting data from 41 diverse cell and tissue
types (Neph et al., 2012a). Each of these 41 samples was treated
with DNaseI, and sites of DNaseI cleavage along the genome
were analyzed with high-throughput sequencing. At an average
sampling depth of 500 million DNaseI cleavages per cell type
(of which 273 million mapped to unique genomic positions),
we identified an average of1.1 million high-confidence DNaseI
footprints per cell type (range 434,000 to 2.3 million at a false
discovery rate of 1% [FDR 1%]; Neph et al., 2012a). Collectively,
we detected 45,096,726 footprints, representing cell-selective
binding to 8.4 million distinct 6–40 bp genomic sequence
elements. We used well-annotated databases of TF-binding
motifs to infer the identities of factors occupying DNaseI foot-
prints (Wingender et al., 1996; Bryne et al., 2008; Newburger
and Bulyk, 2009) (Experimental Procedures) and confirmed
that these identifications matched closely and quantitatively
with ENCODE ChIP-seq data for the same cognate factors
(Neph et al., 2012a).
To generate a TF regulatory network for each cell type, we
analyzed actively bound DNA elements within the proximal regu-
latory regions (i.e., all DNaseI hypersensitive sites within a 10 kb
interval centered on the transcriptional start site [TSS]) of 475 TF
genes with well-annotated recognition motifs (Wingender et al.,
1996; Bryne et al., 2008; Newburger andBulyk, 2009) (Figure 1A).
Repeating this process for every cell type disclosed a total of
38,393 unique, directed (i.e., TF-to-TF) regulatory interactions
(edges) among the 475 analyzed TFs, with an average of
11,193 TF-to-TF edges per cell type (Data S1). Given the func-
tional redundancy of a minority of DNA-binding motifs (Berger
et al., 2008), in certain cases multiple factors could be desig-
nated as occupying a single DNaseI footprint. However, most
commonly, mappings represented associations between single
TFs and a specific DNA element. Because DNaseI hypersensi-
tivity at proximal regulatory sequences closely parallels gene
expression (The ENCODE Project Consortium, 2012), the anno-
tation process we utilized naturally focuses on the expressed TF
complement of each cell type, enabling the construction of
a comprehensive transcription regulatory network for a given
cell type with a single experiment.
De Novo-Derived Networks Accurately Recapitulate
Known TF-to-TF Circuitry
To assess the accuracy of cellular TF regulatory networks
derived from DNaseI footprints, we analyzed several well-anno-
tated mammalian cell-type-specific transcriptional regulatory
subnetworks (Figures 1B and 1C). The muscle-specific factors
MyoD, Myogenin (MYOG), MEF2A, and MYF6 form a network
that was uncovered using a combination of genetic and physical
studies, including DNaseI footprinting, and is vital for specifica-
tion of skeletal muscle fate and control of myogenic develop-
ment and differentiation (Naidu et al., 1995; Yun and Wold,
1996; Ramachandran et al., 2008). Figure 1B juxtaposes the
known regulatory interactions between these factors determinedell 150, 1274–1286, September 14, 2012 ª2012 Elsevier Inc. 1275
A Generate network3)
Repeat in 41 cell-types
using all 475 TFs with
recognion mofs
4)
Use DNaseI footprints to determine occupied binding elements
within promoter proximal regions of TF genes (+/-5kb of TSS)
1)
Idenfy other TFs
targeted by TF in (1)
2)
IRF1
IRF7
GABPB1
STAT6
B
D
C
E
Skeletal Muscle Myoblasts
(HSMM)
Muscle Regulatory Network
(Naidu et al. 1995; Yun & Wold 1996;
Ramachandran et al. 2008)
Human Embryonic Stem Cells
(H7-hESC)
Mouse Embryonic Stem Cells
(Kim et al. 2008)
Well-described
Networks
De novo derived
Networks
Embryonic Stem Cells (H7-hESC)
Fetal Brain
0.1
0.0
0.2
0.3
0.4
0.5
0.6
0.7
0.9
0.8
41 cell-type speciﬁc networks
Ja
cc
ar
d 
in
de
x 
of
 k
no
w
n 
ne
tw
or
k
w
ith
 d
e 
no
vo
 d
er
iv
ed
 n
et
w
or
ks
0.1
0.0
0.2
0.3
0.4
0.5
0.6
0.7
0.9
0.8 Skeletal Myoblasts (HSMM)
Skeletal Muscle (SKMC)
41 cell-type speciﬁc networks
Pulmonary
Fibroblasts Skeletal Muscle
(SKMC)
Ja
cc
ar
d 
in
de
x 
of
 k
no
w
n 
ne
tw
or
k
w
ith
 d
e 
no
vo
 d
er
iv
ed
 n
et
w
or
ks
Figure 1. Construction of Comprehensive Transcriptional Regulatory Networks
(A) Schematic for construction of regulatory networks using DNaseI footprints. Transcription factor (TF) genes represent network nodes. Each TF node has
regulatory inputs (TF footprints within its proximal regulatory regions) and regulatory outputs (footprints of that TF in the regulatory regions of other TF genes).
Inputs and outputs comprise the regulatory network interactions ‘‘edges.’’ For example: (1) In Th1 cells, the IRF1 promoter contains DNaseI footprints matching
four regulatory factors (STAT1, CNOT3, SP1, and NFKB). (2) In Th1 cells, IRF1 footprints are found upstream of many other genes (for example, GABP1, IRF7,
STAT6). (3) The same process is iterated for every TF gene in that cell type, enabling compilation of a cell-type network comprising nodes (TF genes) and edges
(regulatory inputs and outputs of TF genes). (4) Network construction is carried out independently using DNaseI footprinting data from each of 41 cell types,
resulting in 41 independently derived cell-type networks.
(B and C) Comparison of well-annotated versus de novo-derived regulatory subnetworks.
(B) Muscle subnetwork. Top, experimentally defined regulatory subnetwork for major factors controlling skeletal muscle differentiation and transcription. Arrows
indicate direction(s) of regulatory interactions between factors. Bottom, regulatory subnetwork derived de novo from the DNaseI footprint-anchored network of
skeletal myoblasts closely matches the experimentally annotated network.
(C) Pluripotency subnetwork. Top, regulatory subnetwork for major pluripotency factors defined experimentally in mouse ESCs (Kim et al., 2008). Bottom,
regulatory subnetwork derived de novo from human ESCs is virtually identical to the annotated network.
1276 Cell 150, 1274–1286, September 14, 2012 ª2012 Elsevier Inc.
in the aforementioned studies (Figure 1B, top) with the nearly
identical interactions derived de novo from analysis of the
network computed using DNaseI footprints mapped in primary
human skeletal myoblasts (HSMM) (Figure 1B, bottom).
OCT4, NANOG, KLF4, and SOX2 together play a defining role
in maintaining the pluripotency of embryonic stem cells (ESCs)
(Takahashi and Yamanaka, 2006; Takahashi et al., 2007), and a
network comprising the mutual regulatory interactions between
these factors has been mapped through systematic studies of
factor occupancy by ChIP-seq in mouse ESCs (Kim et al.,
2008) (Figure 1C, top). A nearly identical subnetwork emerges
from analysis of the TF network computed de novo from DNaseI
footprints in human ESCs (Figure 1C, bottom).
Critically, both the well-annotated muscle and ES sub-
networks are best matched by footprint-derived networks
computed specifically from skeletal myoblasts and human
ESCs, respectively, versus other cell types (Figures 1D and
1E). These findings indicate that network relationships between
TFs derived de novo from genomic DNaseI footprinting accu-
rately recapitulate well-described cell-type-selective transcrip-
tional regulatory networks generated with multiple experimental
approaches.
TF Regulatory Networks Show Marked Cell Selectivity
We next analyzed systematically the dynamics of TF regulatory
networks across cell types. Four hundred and seventy-five
TFs theoretically have the potential for 225,625 combinations
of TF-to-TF regulatory interactions (or network edges). However,
only a fraction of these potential edges are observed in each cell
type (5%), and most are unique to specific cell types (Fig-
ure S1A available online).
To visualize the global landscape of cell-selective versus
shared regulatory interactions, we first computed the broad
landscape of network edges that are either specific to a given
cell type or found in networks of two or more cell types (Figure 2;
Table S1). This revealed that regulatory interactions were in
general highly cell selective, though the proportion of cell-selec-
tive interactions varied from cell type to cell type. Network edges
were most frequently restricted to a single cell type, and collec-
tively the majority of edges were restricted to four or fewer cell
types (Figure S1A). By contrast, only 5% of edges were common
to all cell types (Figure S1A). Interestingly, when comparing
networks, we found more common edges than common DNaseI
footprints (Figures S1B and S1C), implying that a given transcrip-
tional regulatory interaction can be generated using distinct
DNA-binding elements in different cell types.
To explore the regulatory interaction dynamics of limited
sets of related factors, we plotted the regulatory network
edges connecting four hematopoietic regulators and four plurip-
otency regulators in six diverse cell types (Figure 3A). This anal-
ysis clearly highlighted the role of cell-type-specific factors
within their cognate cell types: regulatory interactions between(D and E) De novo-derived subnetworks in (B) and (C) match the annotated networ
similarity, comparing the annotated subnetwork with regulatory interactions betw
(horizontal axes). For the annotated muscle subnetwork, the highest similarity
contrast, subnetworks computed from fibroblasts are largely devoid of relevant in
seen in human ESCs (H7-ESC).
Cpluripotency factors within the ESC network and hematopoietic
factors within the network of hematopoietic stem cells (Fig-
ure 3A). Next, we plotted the complete set of regulatory interac-
tions among all 475 edges between the same six diverse cell
types, exposing a high degree of regulatory diversity (Figure 3B;
Table S1).
Edges unique to a cell type typically form a well-connected
subnetwork (Figures S1D–S1F; Table S2), implying that cell-
type-specific regulatory differences are not driven merely by
the independent actions of a few TFs but rather by organized
TF subnetworks. In addition, the density of cell-selective net-
works varies widely between cell types (e.g., compare ESCs to
skeletal myoblasts in Figure 3B). These observations underscore
the importance of using cell-type-specific regulatory networks
when addressing specific biological questions.
Functionally Related Cell Types Share Similar Core
Transcriptional Regulatory Networks
We next sought to determine the degree of relatedness between
different TF networks. To obtain a quantitative global summary
of the factors contributing to each cell-type-specific network,
we computed for each cell type the normalized network degree
(NND)—a vector that encapsulates the relative number of inter-
actions observed in that cell type for each of the 475 TFs
(Alon, 2006). To capture the degree to which different cell-type
networks utilize similar TFs, we clustered all cell-type net-
works based on their NND vector (Figure 4A). The resulting
network clusters—obtained from an unbiased analysis—strik-
ingly parallel both anatomical and functional cell-type groupings
into epithelial and stromal cells; hematopoietic cells; endothelia;
and primitive cells including fetal cells and tissues, ESCs, and
malignant cells with a ‘‘dedifferentiated’’ phenotype (Figure 4A;
compare the manually curated groupings in Figure 2). This
result suggests that transcriptional regulatory networks from
functionally similar cell types are governed by similar factors.
Furthermore, this result suggests a framework for understanding
how minor perturbations in network composition might enable
transdifferentiation among related cell types (Graf and Enver,
2009).
To identify the individual TFs driving the clustering of related
cell-type networks, we computed the relative NND (i.e., the
normalized number of connections) of each TF across the 41
cell types. This approach uncovered numerous specific factors
with highly cell-selective interaction patterns, including known
regulators of cellular identity important to functionally related
cell types (Figure 4B). For instance, PAX5 is most highly con-
nected in B cell regulatory networks, concordant with its function
as a major regulator of B-lineage commitment (Nutt et al., 1999).
Similarly, the neuronal developmental regulator POU3F4 (Shima-
zaki et al., 1999)playsaprominent role specifically inhippocampal
astrocyte and fetal brain regulatory networks, whereas the
cardiac developmental regulator GATA4 (Molkentin et al., 1997)ks in a cell-specific fashion. Vertical axes: Jaccard index, a measure of network
een the four factors derived de novo from each of 41 cell types independently
is seen in skeletal myoblasts, followed by differentiated skeletal muscle. By
teractions. For the annotated pluripotency subnetwork, the highest similarity is
ell 150, 1274–1286, September 14, 2012 ª2012 Elsevier Inc. 1277
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scending order) of their degree (i.e., number of
connections to other TFs) in the ESC network,
from highest degree on top (SP1) to lowest degree
on bottom (ZNF354C). Cell types are grouped
based on their developmental and functional
properties. Insert on bottom right shows a detailed
view of the human ESC network and highlights the
interactions of four pluripotent (KLF4, NANOG,
POU5F1, SOX2) and four constitutive factors
(SP1, CTCF, NFYA, MAX) with purple and green
edges, respectively.shows the highest relative network degree in cardiac and great
vessel tissue (fetal heart, cardiomyocytes, cardiac fibroblasts,
and pulmonary artery fibroblasts).1278 Cell 150, 1274–1286, September 14, 2012 ª2012 Elsevier Inc.In addition to these known develop-
mental regulators, the network analysis
implicated many regulators with previ-
ously unrecognized roles in specification
of cell identity. For instance, HOXD9 is
highly connected specifically in endothe-
lial regulatory networks, and the early
developmental regulator GATA5 (Mac-
Neill et al., 2000) appears to play a
predominant role in the fetal lung network
(Figure 4B), providing functional insight
into the role of GATA5 as a lung tissue
biomarker (Xing et al., 2010). In addition
to factors with strong cell-selective con-
nectivity, we found a number of TFs
with prominent roles in all 41 cell-type
networks, including several known ubiq-
uitous transcriptional and genomic regu-
lators such as SP1, NFYA, CTCF, and
MAX (Figure S2).
Together, the above results demon-
strate the ability of transcriptional net-
works derived from genomic DNaseI
footprinting to pinpoint known cell-selec-
tive and ubiquitous regulators of cel-
lular state and to implicate analogous
yet unanticipated roles for many otherfactors. It is notable that the aforementioned results were
derived independently of gene expression data, highlighting
the ability of a single experimental paradigm (genomic DNaseI
BA
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See also Figure S1 and Table S2.footprinting) to elucidate multiple intricate transcriptional regula-
tory relationships.
Network Analysis Reveals Cell-Type-Specific Behaviors
for Widely Expressed TFs
Many TFs are expressed to varying degrees in a number of
different cell types (Vaquerizas et al., 2009). A major question
is whether the function of widely expressed factors remains
essentially the same in different cells, or whether such factors
are capable of exhibiting important cell-selective actions. To
explore this question, we sought to characterize the regulatory
diversity between different cell types within the same lineage.
Hematopoietic lineage cells have been extensively characterized
at both the phenotypic and the molecular levels, and a cadre
of major transcriptional regulators, including TAL1/SCL, PU.1,
ELF1, HES1,MYB, GATA2, andGATA1, has been defined (Orkin,
1995; Swiers et al., 2006). Many of these factors are expressed
to varying degrees across multiple hematopoietic lineages and
their constituent cell types.
We analyzed de novo-derived subnetworks comprising the
aforementioned seven regulators in five hematopoietic and one
nonhematopoietic cell type (Figure 5A). For each cell-type sub-
network, we also mapped the normalized outdegree (i.e., the
number of outgoing connections) for each factor (Figure 5A).
This analysis revealed both subtle and stark differences in the
organization of the seven-member hematopoietic regulatory
subnetwork that reflected the biological origin of each cellCtype. For example, the early hematopoietic fate-decision factor
PU.1 appears to play the largest role in the subnetworks gener-
ated from hematopoietic stem cells (CD34+) and promyelocytic
leukemia (NB4) cells (Figure 5A). The erythroid-specific regulator
GATA1 appears as a strong driver of the core TAL1/PU.1/HES1/
MYB subnetwork specifically within erythroid cells (Figure 5A),
consistent with its defining role in erythropoiesis. In both B cells
and T cells, the subnetwork takes on a directional character, with
PU.1 in a superior position. By contrast, the subnetwork is largely
absent in nonhematopoietic cells (muscle, HSMM) (Figure 5A,
bottom right). These findings demonstrate that analysis of the
network relationships of major lineage regulators provides a
powerful tool for uncovering subtle differences in transcriptional
regulation that drive cellular identity between functionally similar
cell types.
We next extended this analysis to determine whether we could
identify commonly expressed factors that manifest cell-type-
specific behaviors. For example, the retinoic acid receptor-
alpha (RAR-a) is a constitutively expressed factor involved in
numerous developmental and physiological processes (Sucov
et al., 1996). Rather than simply measuring the degree of con-
nectivity of RAR-a to other factors across different cell types,
we sought to quantify the behavior of RAR-a within each cellular
regulatory network by determining its position within feedfor-
ward loops (FFLs). FFLs represent one of the most important
network motifs in biological and regulatory systems and com-
prise a three-node structure in which information is propagatedell 150, 1274–1286, September 14, 2012 ª2012 Elsevier Inc. 1279
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Figure 4. Functionally Related Cell Types Share Similar Core Transcriptional Regulatory Networks
(A) Clustering of cell-type networks by normalized network degree (NND). For each of 475 TFs within a given cell-type network, the relative number of edges was
compared between all 41 cell types using a Euclidean distance metric and Ward clustering. Cell types are colored based on their physiological and/or functional
properties.
(B) Relative degree of master regulatory TFs in cell-type networks. Shown is a heatmap representing the relative normalized degree of the indicated TFs between
each of the 41 cell types. For a given TF and cell type, high relative degree indicates high connectivity with other TFs in that cell type. Note that the relative degree
of known regulators of cell fate such as MYOD, OCT4, or MYB is highest in their cognate cell type or lineage. Similar patterns were found for other TFs without
previously recognized roles in specification of cell identify.
See also Figure S2.forward from the top node through the middle to the bottom
node, with direct top node-to-bottom node reinforcement (Milo
et al., 2002; Alon, 2006). For each cell type, we quantified
the number of FFLs containing RAR-a at each of the three
different positions (top versus middle versus bottom; Figure 5B,
top). In most cell types, RAR-a chiefly participates in FFLs at
‘‘passenger’’ positions 2 and 3 (Figure 5B). However, within
blood and endothelial cells, RAR-a switches from being a
passenger to being a driver (top position) of FFLs. Strikingly, in
acute promyelocytic leukemia (APL) cells, RAR-a acts as a
uniquely potent driver of FFLs, occurring exclusively in the driver
position—a feature unique among all cell types (Figure 5B).
APL is characterized by an oncogenic t(15;17) chromosomal
translocation that results in a RAR-a/PML fusion protein that
misregulates RAR-a target sites (Grignani et al., 1993, 1998).
Our results suggest that in APL cells, RAR-a is additionally
altering the basic organization of the regulatory network. Criti-
cally, using DNaseI footprint-driven network analysis, we identi-
fied the prominent role of RAR-a in APL cells without any prior1280 Cell 150, 1274–1286, September 14, 2012 ª2012 Elsevier Inc.knowledge of the role of RAR-a in the oncogenic transformation
of APL cells. This suggests that network analysis is capable of
deriving vital pathogenic information about specific factors in
abnormal cell types, given a sufficient analyzed spectrum of
normal cellular networks. On amore general level, the aforemen-
tioned results show clearly that marked cell-selective functional
specificities of commonly expressed proteins can be exposed
by analyzing factors within the context of their peers.
The Common ‘‘Neural’’ Architecture of Human TF
Regulatory Networks
Complex networks from diverse organisms are built from a set
of simple building blocks termed network motifs (Milo et al.,
2002). Network motifs represent simple regulatory circuits,
such as the FFL described above. The topology of a given net-
work can be reflected quantitatively in the normalized frequen-
cies (normalized z-score) of different network motifs. Specific
well-described motifs including FFL, ‘‘clique,’’ ‘‘semi-clique,’’
‘‘regulated mutual,’’ and ‘‘regulating mutual’’ are recurrently
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Figure 5. Cell-Selective Behaviors of Widely Expressed TFs
(A) Shown are regulatory subnetworks comprising edges (arrows) between seven major hematopoietic regulators in five hematopoietic and one non-
hematopoietic cell types. For each TF, the size of the corresponding colored oval is proportional to the normalized out-degree (i.e., out-going regulatory
interactions) of that factor within the complete network of each cell type. The early hematopoietic fate decision factor PU.1 appears to play the largest role in
hematopoietic stem cells (CD34+) and in promyelocytic leukemia (NB4) cells. The erythroid-specific regulator GATA1 appears as a strong driver of the core TAL1/
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position. By contrast, the network is largely absent in nonhematopoietic cells (muscle, HSMM, bottom right).
(B) Heatmap showing the frequency with which RAR-a is positioned as a driver (top) or passenger (middle or bottom) within FFLs mapped in 41 cell-type
regulatory networks. Note that in most cell types, RAR-a participates in FFLs at ‘‘passenger’’ positions 2 and 3. However, within blood and endothelial cells,
RAR-a switches from being a passenger of FFLs to being a driver (top position) of FFLs. In acute promyelocytic leukemia cells (NB4), RAR-a acts exclusively as
a potent driver of FFLs. Cell types are arranged according to the clustered ordering in Figure 4.found at higher than expected frequencies within diverse biolog-
ical networks (Milo et al., 2002, 2004). We therefore sought to
analyze the topology of the human TF regulatory network and
to compare it with those of well-annotated multicellular biolog-
ical networks.
We first computed the relative frequency and relative enrich-
ment or depletion of each of the 13 possible three-node network
motifs within each cell-type regulatory network. Next, we com-
pared the results for each cell-type network with the relative
enrichment of three-node network motifs found in perhaps the
best annotated multicellular biological network, the C. elegans
neuronal connectivity network (White et al., 1986). This compar-
ison revealed striking similarity between the topologies of human
TF networks and the C. elegans neuronal network (Figure 6A;
Table S3). Remarkably, in spite of their cell selectivity, the topol-
ogies of each TF network were nearly identical. Notably, the
human TF regulatory network topology also closely resembles
that of other well-described networks, including the sea-urchin
endomesoderm specification network (Davidson et al., 2002a),
the Drosophila developmental transcriptional network (Serov
et al., 1998), and the mammalian signal transduction networkC(Milo et al., 2004) (Figure S3A), consistent with universal princi-
ples for multicellular biological information processing systems
(Milo et al., 2004).
To test the sensitivity of the above findings to the manner in
which the human transcriptional regulatory networks were deter-
mined, we recomputed this network solely from scanned TF-
binding sites within the promoter-proximal regions of each TF
gene, without considering whether the motifs were localized
within DNaseI footprints. Using this approach, the remarkable
similarity of the footprint-derived TF networks to the neuronal
network was almost completely lost (Figure 6B). This result
affirms the criticality of in vivo footprints for biologically meaning-
ful network inference.
Next, we sought to determine whether the observed similarity
to the neuronal network was a collective property of human TF
networks. To test this, we computed a transcriptional regulatory
network from the combined regulatory interactions of all 41 cell
types and determined the enrichment of network motifs within
this network. The resulting network topology diverges consider-
ably from that of the neuronal network (Figure 6C), far more so
than was observed for any individual cell type (Figure 6A). Thisell 150, 1274–1286, September 14, 2012 ª2012 Elsevier Inc. 1281
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Figure 6. Conserved Architecture of Human TF Regulatory Networks
(A) Shown is the relative enrichment or depletion of the 13 possible three-node architectural network motifs within the regulatory networks of each cell type (red
lines), compared with the relative enrichment of the same motifs in the C. elegans neuronal connectivity network. Note that the network architecture of each
individual cell type closely mirrors that of the living neuronal network (average SSE of only 0.0705).
(B) Enrichment of each triad network motif for a TF network computed using only motif scan predictions within ± 5 kb of TF promoters (brown line). The resulting
network bears little resemblance to the C. elegans network (blue line) (SSE of 2.536).
(C) The relative enrichment of different triad network motifs is shown for a TF regulatory network generated by pooling DNaseI footprints from all 41 tested cell
types into a single archetype (orange line). The resulting topology diverges considerably from that of the neuronal network, far more so than was observed for any
individual cell type (SSE of 0.4308).
(D and E) Network architectures are highly cell specific. (D) Overlap of FFLs identified in three different progenitor cell types—ESCs (H7-hESC), hematopoietic
stem cells (CD34+), and HSMM. Note that most FFLs are restricted to an individual cell type.
(E) Overlap of FFLs identified in three pulmonary cell types—lung fibroblasts (NHLF), small airway epithelium cells (SAECs), and pulmonary lymphatic endothelium
cells (HMVEC_LLy). Highly distinct architectures are present even among cell types from the same organ structure.
(F) Overlap of FFLs from networks of neighboring cell types, following the ordering and coloration shown in Figure 4A. The size of each circle is proportional to the
number of FFLs contained within the network of the corresponding cell type. The color of the intersection region between adjacent cell types indicates the
Jaccard index between FFLs from those two cell types (see legend in upper right). The average number of FFLs in each network, the total number of FFLs across
all networks, and the number of common FFLs across all networks are indicated in the center of the graph.
See also Figure S3 and Table S3.result suggests that the regulatory interactions within each cell-
type network are independently balanced to achieve a specific
architecture, and that pooling multiple cellular networks together
degrades this balance.
Finally, to assess whether a common core of regulatory inter-
actions might be driving the conserved network architecture,
we compared FFLs between biologically similar cell types. This
comparison revealed marked diversity among different cellular1282 Cell 150, 1274–1286, September 14, 2012 ª2012 Elsevier Inc.TF networks (Figures 6D and 6E), going beyond that observed
among individual edges (Figures S3C and S3D). Indeed, only
0.1% of all observed FFLs across 41 cell types (784/558,841)
were common to all cell types (Figures 6F and S3E). Moreover,
only a minority of the TFs represented within a given cellular
network contribute to the enriched network motifs (Figure S3F).
These findings indicate that the conserved ‘‘neuronal’’ network
architecture (Figure 6A) of the human TF regulatory network is
specified independently in each cell type using a distinct set of
balanced regulatory interactions.
DISCUSSION
TF regulatory networks are foundational to biological systems.
Collectively, our results highlight the power of regulatory net-
works derived from genomic DNaseI footprint maps to provide
accurate large-scale depictions of regulatory interactions in
human cells, and they suggest that such interactions are gov-
erned by a core set of organizing principles shared with other
multicellular information processing systems.
In a classic treatise, Waddington proposed that the epigenetic
landscape of a cell is ‘‘buttressed’’ by complex interactions
among multiple regulatory genes (Waddington, 1939, elabo-
rated in Waddington, 1957). These genes—now recognized as
sequence-specific transcriptional regulators—form an extended
‘‘cognitive’’ network that enables the simultaneous integration of
multiple internal and external cues and conveys this information
to specific effector genes along the genome. Consequently,
transcriptional regulatory networks influence both the current
chromatin landscape of a cell as well as its epigenetic state, im-
parting a type of ‘‘memory’’ that may impact subsequent cellular
fate decisions (Waddington, 1957; Groudine and Weintraub,
1982). Such characteristics render TF regulatory networks ideal
for governing complex processes such as pluripotency (Boyer
et al., 2005; Kim et al., 2008), development (Davidson et al.,
2002a), and differentiation (Yun and Wold, 1996). However,
despite their central role in human pathology and physiology,
human transcriptional regulatory networks are presently poorly
understood.
The networks we describe here for 41 diverse cell types
provide an extensive description of the circuitry, dynamics,
and organizing principles of the human TF regulatory network.
The derivation of regulatory networks from genomic DNaseI
footprint maps provides a general, scalable solution for mapping
and analyzing cell-selective transcriptional regulatory networks
in complex multicellular organisms. By comparison, generation
of networks of this size across 41 cell types using traditional
approaches such as perturbation or ChIP-seq would have
required nearly 20,000 individual experiments. By contrast, the
approach we describe can readily scale beyond the 475 factors
analyzed in the current study and is constrained only by the avail-
ability of accurate TF recognition sequences.
Our analysis of transcriptional regulatory interactions in a
network context has uncovered several novel features of human
transcriptional regulation, some quite striking.
First, we observed that human transcriptional regulatory net-
works are markedly cell type specific, with only 5% of all regu-
latory interactions common across the 41 tested cell types. This
finding highlights the regulatory diversity within humans and
underscores the importance of analyzing cell-selective regula-
tory networks when addressing specific biological questions.
Second, by detecting factors that predominantly contribute to
the transcriptional regulatory networks of only one or a few cell
types, we identified both known and novel regulators of cellular
identity (Figure 4B). Differences between cell types thus encode
a surprisingly rich landscape of information concerning differen-Ctiation and developmental processes, and this landscape can be
systematically mined for regulatory insights.
Third, we found that commonly expressed TFs within a given
cell lineage play distinct roles in the governance of regulatory
networks of different cells within that lineage. Our analysis
discovered that in acute promyelocytic leukemia cells, thewidely
expressed RAR-a shifts from being a passenger of FFLs to being
a strong driver of FFLs. This finding provides insights into the
broader—and more fundamental—regulatory alterations that
accompany the RAR-a/PML fusion protein unique to acute pro-
myelocytic leukemia. On a general level, our results show that
commonly expressed proteins may display highly cell-selective
actions, and that such activities may be brought to light by
analyzing TFs in the context of their peers.
Finally, in marked contrast to the high regulatory diversity
between cell types, we found that all cell-type regulatory net-
works converge on a common network architecture that closely
mirrors the topology of the C. elegans neuronal connectivity
network and those of other multicellular information processing
systems (Milo et al., 2004), highlighting a fundamental similarity
in the structure and organizing principles of these biological
systems. Strikingly, this common architecture is independently
fashioned in each cell type and results from the delicate balance
of distinct regulatory interactions.
Despite the experimental and computational advantages
and successes of our approach, a number of additional steps
could be used to refine and improve our regulatory interaction
networks. First, as noted above, our approach is limited by the
availability of recognition sequences for specific TFs. The
pending availability of both more and higher-quality recognition
sequences through approaches such as protein-binding micro-
arrays (Berger et al., 2008; Badis et al., 2009) and SELEX-seq
(Jolma et al., 2010; Slattery et al., 2011) promises to expand
considerably the horizons of human transcriptional network
analysis. Such refined data may enable differentiation of factors
that currently appear to bind similar recognition sequences.
Second, the model that we described undervalues the role
of distal regulatory elements, which can exert major influences
on gene expression. Because enhancers can act over long
distances, association of a given distal regulatory element with
a specific TF gene is at present difficult. We therefore focused
on footprints in DHSs within a 10 kb region that is centered on
the TSS—a region in which most regulatory interactions are ex-
pected to be directed to the local TSS. Although large numbers
of distal regulatory DNA regions marked by DNaseI-hypersensi-
tive sites are now available through the ENCODE (The ENCODE
Project Consortium, 2012) and Roadmap Epigenomics (Bern-
stein et al., 2010) projects, the assignment of distal regulatory
elements to their cognate gene(s) has proven to be a formidable
challenge. Third, the approach we utilized does not take into
account indirect regulatory interactions (e.g., tethering) that
may affect the expression of a given TF gene (Davidson et al.,
2002b; Rigaud et al., 1991; Biddie et al., 2011). Systematic
cross-comparisons between DNaseI footprint and TF ChIP-seq
data drawn from the same cell type should enable recognition
of such indirect interactions and derivation of rules (e.g., teth-
ering partners) that may enable larger-scale modeling of such
interactions (Neph et al., 2012a).ell 150, 1274–1286, September 14, 2012 ª2012 Elsevier Inc. 1283
In order to interpret human regulatory networks at the organ-
ismal level, it will be necessary to analyze cell-selective regula-
tory networks within the context of surrounding tissues (Baraba´si
and Oltvai, 2004). As initially described by Spemann over 90
years ago, the identity of a given cell can be largely dictated by
its surrounding tissue (Spemann, 1918). Consequently, during
both normal development and physiological function, the regula-
tory landscape of one cell type may become intricately depen-
dent upon that of its neighbors (reviewed in Waddington,
1940). In this context, it is notable that we observed large diver-
sity between the regulatory landscapes of distinct lung cell types
(Figure 6E), which highlights the complexity that exists within
neighboring tissue from the same organ.
In summary, our results provide a description of the circuitry,
dynamics, and organizing principles of the human TF regula-
tory network. Systematically applied, the approach we have
described has the potential to expand greatly our horizons on
the mechanism, architecture, and epistemology of human gene
regulation.
EXPERIMENTAL PROCEDURES
Regulatory Network Construction
We used GeneCards (Rebhan et al., 1997) and UniProt Knowledgebase
(Magrane and Consortium, 2011) to map motif-binding protein information
found in TRANSFAC to 538 coding genes. Some genes were indistinguishable
when viewed from a potential motif-binding event perspective, as their
respective gene products were annotated as binders to the same set of
motif templates by TRANSFAC. In such cases, we chose a single gene,
randomly, as a representative and removed others, which reduced the
number of genes from 538 to 475. Networks built by removing the first redun-
dant motif, alphabetically, or by including all redundant motifs showed very
similar properties to the one described in this paper (Figure S3B and data
not shown).
We symmetrically padded the TSSs of the remaining genes by 5 kb and
scanned for predicted TRANSFAC motif-binding sites using FIMO (Bailey
et al., 2009), version 4.6.1, with a maximum p value threshold of 1 3 105
and defaults for other parameters. For each cell type, we filtered putative
motif-binding sites to those that overlapped footprints as previously described
(Neph et al., 2012a). Each network contained 475 nodes, one per gene. A
directed edge was drawn from a gene node to another when a motif instance,
potentially bound by the first gene’s protein product, was found within a
DNaseI footprint contained within 5 kb of the second gene’s TSS, indicating
regulatory potential. Table S3 shows the number of such edges in every cell-
type-specific network.
Network Clustering
We counted the total number edges for every TF gene node (sum of in and out
edges) in a cell type and calculated the proportion of edges for that TF relative
to all edges (NND). We used the NND vectors to compute the pairwise
euclidean distances between cell types, andwe usedWard clustering to group
the cell types (Ward, 1963). We observed similar cluster patterns when
comparing normalized in-degree, normalized out-degree, or un-normalized
total degree (results not shown).
Triad Significance Profiles
We removed self-edges from every network and used the mfinder software
tool for network motif analysis (Milo et al., 2004). A z-score was calculated
over each of 13 network motifs of size 3 (three-node network motifs), using
250 randomized networks of the same size to estimate a null. We vectorized
z-scores from every cell type and normalized each to unit length to create triad
significance profiles (TSP) as described in Milo et al. (2004). We computed the
average TSP over all cell-type-specific regulatory networks and compared to1284 Cell 150, 1274–1286, September 14, 2012 ª2012 Elsevier Inc.the TSP of the highly curated multicellular information processing networks
described in Milo et al. (2004).
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WEB RESOURCES
A TF network browser is available for visualization and comparison of cell-type
TF networks and subnetworks: http://www.regulatorynetworks.org/.
The browser can be used to display thewiring of any selected group of TFs and
to examine their dynamics across different cell types.
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